Virbac is a French animal health company that specialises in the development of pharmaceuticals, nutritional supplements, and vaccines for companion animals, ruminants such as cattle, sheep and goats, aquaculture species, and swine. The company is particularly strong in aquaculture, where it ranks among the top four global suppliers.

Revenue is derived approximately sixty percent from companion animals and forty percent from food-producing animals. Notable products include the C.E.T. dental range for dogs and cats, HPM pet nutrition for companion animals, and Bovigen vaccines for cattle.

Virbac generates forty-one percent of its revenue from Europe and sixteen percent from Latin America. North America contributes only thirteen percent, where the company holds an estimated market share of two percent.